{"schemaVersion":1,"research":true,"symbol":"vtr","name":"Ventas","topic":"moat","path":"/stock/vtr/moat","status":"published","version":4,"updatedAt":"2026-10-18T13:34:28.034Z","locked":false,"publicFairValue":false,"fairValue":null,"moat":{"verdict":"none","summary":"The supplied disclosures support no established durable moat: Ventas explicitly reports limited development barriers, particularly in senior housing, which supplied 58.2% of first-half 2026 NOI. Scale, hospital-linked locations and analytics provide operating capabilities, but demonstrated competitive protection is absent. This does not imply weak current operations: 2025 RevPOR increased 4.7%, occupancy improved and cash generation grew. Pricing strength is demonstrated for that period, while its durability through new supply remains unproven.","advantages":[{"mechanism":"intangible_assets","claim":"Existing hospital-linked outpatient locations provide potential location and relationship advantages: 96% of the outpatient medical portfolio was affiliated with health systems or hospitals. The passages do not demonstrate exclusivity, tenant switching costs or sustained rent premiums.","durability":"Physical locations can persist, but affiliation alone does not establish protected demand or durable pricing power.","risks":"Hospital competitiveness, funding pressures and restrictions on alternative property uses can weaken the value of these relationships and locations.","invalidation":"The location-advantage thesis would be undermined by affiliated properties losing tenants or accepting weaker renewal terms despite continued hospital affiliation. Exclusive access or sustained superior renewal economics would challenge the present no-moat assessment.","competitors":[],"evidenceIds":["e1","e2"],"counterEvidenceIds":["e3","e4"]},{"mechanism":"cost_advantage","claim":"Portfolio scale, access to capital and proprietary analytics are potential sources of operating efficiency. Capital raising and operating growth are demonstrated, but a lower cost than competitors or a defensible analytics advantage is not.","durability":"The platform is established, but the passages provide no comparative cost evidence or demonstrated barrier to replication. Industry demand growth benefits other owners as well.","risks":"Limited development barriers permit competing supply; reliance on third-party operators limits direct control. Equity-funded expansion can increase scale without necessarily improving returns per share.","invalidation":"Persistent occupancy or pricing deterioration after competing supply arrives would undermine the platform-advantage thesis. Sustained comparative cost savings and superior returns through a supply cycle would challenge the present no-moat assessment.","competitors":[],"evidenceIds":["e5","e6","e7","e8"],"counterEvidenceIds":["e9","e10","e11"]}],"evidence":[{"id":"e1","sourceId":"filing-3","location":"About Ventas / portfolio characteristics","excerpt":"SENIOR HOUSING(1) The world's second largest owner of senior housing(2), delivering valuable benefits to residents in a time of unprecedented demand 875 communities across the United States, Canada and the United Kingdom 93K+ seniors served 40+ operators OUTPATIENT MEDICAL AND RESEARCH(1) Supporting growing demand for outpatient medical care and research that enhances health, longevity and quality of life ~21M square feet of outpatient medical (OM) space(3) 40M+ patient visits each year 96% of OM portfolio affiliated with health systems or hospitals TRIPLE-NET HEALTHCARE(1) Enabling critical care and healing in specialized facilities 8K patient beds 1.9M patient days annually(4) VENTAS INVESTMENT MANAGEMENT(1) Creating value for institutional capital partners and Ventas stockholders through our third-party institutional private capital management platform ~$5B assets under management 280%+ fund growth since inception (1)Data as of December 31, 2025, unless otherwise noted (2)Company supplemental reports and 2024 ASHA Top Owners list (3)Represents consolidated and unconsolidated properties and investments in process and developments underway (4)As of September 30, 2025 2026 | Proxy Statement 3 About Ventas Summary Board & Governance Compensation Audit Matters Securities Ownership More 2025 Performance Highlights Ventas’s strong results in 2025 demonstrate the power of our strategy and execution and our role as a preeminent participant in a rapidly growing market fueled by demographic demand."},{"id":"e2","sourceId":"filing-5","location":"Business / outpatient medical property locations","excerpt":"Our outpatient medical buildings, which are predominantly located on or contiguous to a health system campus, are generally multi-tenant properties leased to health systems and several unrelated medical practices, although in many cases they may be associated with a large single specialty or multi-specialty group, including neighboring health systems."},{"id":"e3","sourceId":"filing-2","location":"Forward-looking risk discussion / hospital viability and restricted property uses","excerpt":"and the reliance of our managers, tenants and borrowers on the financial, credit and capital markets and the risk that those markets may be disrupted or become constrained; (i) the risk of bankruptcy, inability to obtain benefits from governmental programs, insolvency or financial deterioration of our managers, tenants borrowers and other obligors which may, among other things, have an adverse impact on the ability of such parties to make payments or meet their other obligations to us; (j) our dependency on a limited number of managers and tenants for a significant portion of our revenues and operating income; (k) our exposure to various operational risks, liabilities and claims from our operating assets; (l) our exposure to particular risks due to our specific asset classes and operating markets, such as adverse changes affecting our specific asset classes and the healthcare real estate sector, the competitiveness or financial viability of hospitals on or near the campuses where our outpatient medical buildings are located, our relationships with universities, the level of expense and uncertainty of our research tenants, and the limitation of our uses of some properties we own that are subject to ground lease, air rights or other restrictive agreements; (m) our ownership of properties or operation of business outside of the U.S."},{"id":"e4","sourceId":"filing-2","location":"Triple-Net Lease Performance and Expirations / renewal economics","excerpt":"Also, if our tenants are not able or willing to renew our triple-net leases upon expiration, we may be unable to reposition the applicable properties on a timely basis or on the same or better economic terms, if at all."},{"id":"e5","sourceId":"filing-2","location":"Company Overview / portfolio size","excerpt":"As of June 30, 2026, we owned or had investments in 1,456 properties consisting of 1,420 properties in our reportable segments (“Segment Properties”) and 36 properties held by unconsolidated real estate entities in our non-segment operations."},{"id":"e6","sourceId":"filing-3","location":"Stockholder letter / claimed analytics and platform advantages","excerpt":"2026 | Proxy Statement i First, we are using our advantaged portfolio, operational expertise, proprietary Ventas Operational InsightsTM data analytics and technology platform, financial strength and industry relationships to generate outsized organic growth in our senior housing operating portfolio (SHOP)."},{"id":"e7","sourceId":"filing-2","location":"Equity / settled forward sales","excerpt":"During the six months ended June 30, 2026, we settled 31.4 million shares of common stock under outstanding equity forward sales agreements entered into under the ATM Program for net cash proceeds of $2.5 billion."},{"id":"e8","sourceId":"filing-3","location":"2025 Performance Highlights / per-share and same-store results","excerpt":"Index performance for the full 3‑year period has been adjusted to include Alexandria Real Estate Equities, Inc., with performance for all other periods as reported Achieved Strong Financial and Operating Performance and Robust Year-over-Year Growth For full year 2025, reported per share results were: 2025 2024 $ Change % Change Net Income Attributable to Common Stockholders (\"Attributable Net Income\") $0.54 $0.19 $0.35 184% Nareit Funds From Operations* (\"Nareit FFO\") $3.50 $3.14 $0.36 11 % Normalized Funds From Operations* (\"Normalized FFO\") $3.48 $3.19 $0.29 9 % •Attributable Net Income per share of $0.54 •Normalized FFO* per share of $3.48, an increase of approximately 9% compared to the prior year •Total Company NOI* year-over-year growth of 16% and Total Company Same-Store Cash NOI* year-over-year growth of 8% * Some of the financial measures discussed are non-GAAP measures."},{"id":"e9","sourceId":"filing-1","location":"Risk Factors / limited development barriers","excerpt":"Depending on the jurisdiction, there are limited barriers to developing properties in our asset classes, particularly senior housing."},{"id":"e10","sourceId":"filing-1","location":"Business / reliance on third-party managers","excerpt":"Where we engage a third-party manager, either by choice or as required by REIT tax rules, we generally rely on the third-party managers’ personnel, expertise, technical resources and information systems, risk management processes, proprietary information, good faith and judgment to manage the senior housing communities’ operations efficiently and effectively."},{"id":"e11","sourceId":"filing-2","location":"Consolidated Balance Sheets / outstanding shares and debt","excerpt":"CONSOLIDATED BALANCE SHEETS (In thousands, except per share amounts, unaudited) As of June 30, 2026 As of December 31, 2025 Assets Real estate investments: Land and improvements $ 3,260,895 $ 2,962,738 Buildings and improvements 33,346,737 30,872,598 Construction in progress 253,902 358,811 Acquired lease intangibles 1,937,522 1,680,567 Operating lease assets 316,707 295,838 39,115,763 36,170,552 Accumulated depreciation and amortization (12,622,838) (12,043,619) Net real estate property 26,492,925 24,126,933 Secured loans receivable and investments, net 436,401 143,913 Investments in unconsolidated real estate entities 590,630 617,571 Net real estate investments 27,519,956 24,888,417 Cash and cash equivalents 198,956 741,067 Escrow deposits and restricted cash 24,861 45,070 Goodwill 1,045,816 1,046,072 Assets held for sale 28,744 42,993 Deferred income tax assets, net 3,134 2,797 Other assets 834,429 825,529 Total assets $ 29,655,896 $ 27,591,945 Liabilities and equity Liabilities: Senior notes payable and other debt $ 12,687,789 $ 13,011,016 Accrued interest payable 142,464 143,104 Operating lease liabilities 231,210 208,602 Accounts payable and other liabilities 1,349,477 1,240,820 Liabilities related to assets held for sale 2,584 4,032 Deferred income tax liabilities 30,739 23,409 Total liabilities 14,444,263 14,630,983 Redeemable OP unitholder and noncontrolling interests 509,069 375,154 Commitments and contingencies Equity: Ventas stockholders’ equity: Preferred stock, $1.00 par value; 10,000 shares authorized, unissued — — Common stock, $0.25 par value; 1,200,000 shares authorized, 512,946 and 474,926 shares outstanding at June 30, 2026 and December 31, 2025, respectively 128,237 118,732 Capital in excess of par value 22,478,217 19,976,183 Accumulated other comprehensive loss (31,510) (39,851) Retained earnings (deficit) (7,925,545) (7,527,777) Treasury stock, 0 shares issued — (34) Total Ventas stockholders’ equity 14,649,399 12,527,253 Noncontrolling interests 53,165 58,555 Total equity 14,702,564 12,585,808 Total liabilities and equity $ 29,655,896 $ 27,591,945 See accompanying notes."},{"id":"e12","sourceId":"filing-2","location":"Segment Information / portfolio NOI composition","excerpt":"8 Table of Contents VENTAS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) The following table summarizes information for our portfolio for the six months ended June 30, 2026 (dollars in thousands): Segment NOI (1) Percentage of Total NOI Segment Properties Senior housing operating portfolio (SHOP) $ 777,957 58.2 % 813 Outpatient medical and research portfolio (OM&R) 302,135 22.6 407 Triple-net leased properties (NNN) 241,884 18.1 200 Non-segment (2) 14,310 1.1 n/a $ 1,336,286 100.0 % 1,420 ______________________________ (1) Net Operating Income (“NOI”) is defined as total revenues, less interest and other income, property-level operating expenses and third-party capital management expenses."},{"id":"e13","sourceId":"filing-3","location":"Executive performance assessment / 2025 RevPOR growth","excerpt":"•Achieving Revenue Per Occupied Room (\"RevPOR\") growth of 4.7% with broad-based pricing strength"},{"id":"e14","sourceId":"filing-3","location":"Executive performance assessment / same-store occupancy growth","excerpt":"•Delivering Same-Store average occupancy growth of 300 basis points, led by U.S."},{"id":"e15","sourceId":"filing-3","location":"Executive performance assessment / SHOP same-store cash NOI growth","excerpt":"•Achieving Same-Store Cash NOI growth of over 15%, and U.S."},{"id":"e16","sourceId":"filing-2","location":"Non-GAAP Financial Measures / same-store exclusions","excerpt":"Properties are excluded from Same-Store if they are: (i) sold, classified as held for sale or properties whose operations were classified as discontinued operations in accordance with GAAP; (ii) impacted by significant disruptive events such as flood or fire; (iii) for SHOP, those properties that are currently undergoing a significant disruptive redevelopment; (iv) for OM&R and NNN reportable segments, those properties for which management has an intention to institute, or has instituted, a redevelopment plan because the properties may require major property-level expenditures to maximize value, increase NOI, or maintain a market-competitive position and/or achieve property stabilization, most commonly as the result of an expected or actual material change in occupancy or NOI; or (v) for SHOP and NNN reportable segments, those properties that are scheduled to undergo operator or business model transitions, or have transitioned operators or business models after the start of the prior comparison period."},{"id":"e17","sourceId":"filing-2","location":"Lease income / fixed and variable payments","excerpt":"Rental income from our NNN and OM&R operating leases consists of fixed and variable lease payments."},{"id":"e18","sourceId":"filing-2","location":"Lease income / reimbursements and percentage rent","excerpt":"The variable payments primarily represent (i) amounts that certain tenants pay to reimburse us for property-level operating expenses that we pay on their behalf and (ii) percentage rent, which is a rental charge typically based on certain tenants' gross revenue."},{"id":"e19","sourceId":"filing-2","location":"Liquidity / triple-net capital expenditure obligations","excerpt":"The terms of our triple-net leases generally obligate our tenants to pay all capital expenditures necessary to maintain and improve our triple-net leased properties."},{"id":"e20","sourceId":"filing-2","location":"Consolidated Statements of Cash Flows / operating cash generation, investment and financing","excerpt":"CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands, unaudited) For the Six Months Ended June 30, 2026 2025 Cash flows from operating activities: Net income $ 131,268 $ 119,818 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 790,179 669,244 Amortization of deferred revenue and lease intangibles, net (9,263) (19,364) Other non-cash amortization 17,185 14,059 Stock-based compensation 30,154 26,510 Straight-lining of rental income (14,113) (12,547) Loss on extinguishment of debt, net 532 — Gain on real estate dispositions (15,222) (33,985) Gain on real estate loan investments (11) — Income tax benefit (48,255) (13,032) Loss from unconsolidated entities 15,161 4,449 Distributions from unconsolidated entities 18,250 15,026 Other 3,580 (2,752) Changes in operating assets and liabilities: Decrease in other assets 13,304 51,523 Decrease in accrued interest payable (1,407) (13,893) Increase (decrease) in accounts payable and other liabilities 19,814 (8,574) Net cash provided by operating activities 951,156 796,482 Cash flows from investing activities: Net investment in real estate property (2,448,803) (960,727) Investment in loans receivable (301,457) (581) Proceeds from real estate disposals 52,574 149,014 Proceeds from loans receivable 7,146 7,848 Redevelopment and development project expenditures (149,676) (125,538) Other capital expenditures (174,797) (133,977) Distributions from unconsolidated entities 11,212 — Investment in unconsolidated entities (18,436) (24,855) Insurance proceeds for property damage claims 2,932 652 Net cash used in investing activities (3,019,305) (1,088,164) Cash flows from financing activities: Net change in borrowings under revolving credit facilities — (5,422) Net change in borrowings under commercial paper program 264,971 — Proceeds from debt 891,730 587,199 Repayment of debt (1,678,830) (1,209,580) Payment of deferred financing costs (7,306) (8,908) Issuance of common stock, net 2,548,239 1,064,749 Cash distributions to common stockholders (483,538) (415,989) Cash distributions to redeemable OP unitholders (3,310) (3,127) Cash issued for redemption of OP Units (2,844) (1,684) Contributions from noncontrolling interests 1,228 80 Distributions to noncontrolling interests (8,152) (6,086) Proceeds from stock option exercises 13,796 26,124 Other (28,397) (19,526) Net cash provided by financing activities 1,507,587 7,830 Net decrease in cash, cash equivalents and restricted cash (560,562) (283,852) Effect of foreign currency translation (1,758) 3,376 Cash, cash equivalents and restricted cash at beginning of period 786,137 957,233 Cash, cash equivalents and restricted cash at end of period $ 223,817 $ 676,757 See accompanying notes."},{"id":"e21","sourceId":"filing-2","location":"Note 5 / first-half 2026 real estate impairments","excerpt":"For the six months ended June 30, 2026, we recognized impairments of $60.3 million comprising $30.7 million, $25.5 million and $4.1 million in our SHOP, OM&R and NNN segments, respectively."},{"id":"e22","sourceId":"filing-3","location":"Appendix / net debt and adjusted EBITDA reconciliation","excerpt":"Additional information regarding Net Debt to Further Adjusted EBITDA is as follows: Net Debt to Further Adjusted EBITDA For the Three Months Ended December 31, 2025 2024 (Dollars in thousands USD; totals may not sum due to rounding; unaudited) Net income attributable to common stockholders $70,202 $56,835 Adjustments: Interest expense 154,468 153,206 Loss on extinguishment of debt, net 53 15 Taxes (including tax amounts in general, administrative and professional fees) (105) (44,153) Depreciation and amortization 352,723 308,772 Non-cash stock-based compensation expense 6,319 4,648 Transaction, transition and restructuring costs (6,008) 4,226 Net income attributable to noncontrolling interests, adjusted for partners’ share of consolidated entity EBITDA (8,383) (6,902) Income from unconsolidated entities, adjusted for Ventas’ share of EBITDA from unconsolidated entities 42,820 24,368 Gain on real estate dispositions (3,311) (6,727) Unrealized foreign currency gain 644 362 Loss on derivatives, net — 21,173 Significant disruptive events, net (297) 2,603 Other normalizing items, net 9 7,446 Adjusted EBITDA $609,134 $525,872 Adjustment for current period activity (1,614) 15,885 Further Adjusted EBITDA $607,520 $541,757 Further Adjusted EBITDA annualized $2,430,080 $2,167,028 Total debt $13,011,016 $13,522,551 Cash and cash equivalents (741,067) (897,850) Restricted cash pertaining to debt (24,845) (32,588) Partners’ share of consolidated debt (328,171) (310,881) Ventas’ share of unconsolidated debt 732,515 676,839 Net debt $12,649,448 $12,958,071 Net debt / Further Adjusted EBITDA 5.2 x 6.0 x The Company believes that Net debt and Further Adjusted EBITDA are useful to investors, analysts and Company management because they allow the comparison of the Company’s credit strength between periods and to other real estate companies without the effect of items that by their nature are not comparable from period to period."},{"id":"e23","sourceId":"filing-3","location":"Executive Compensation / 2025 CEO incentive mix","excerpt":"Our CEO's long-term incentive opportunity for 2025 was in the form of 70% PSUs and 30% RSUs."},{"id":"e24","sourceId":"filing-3","location":"2023–2025 PSU Performance and Payouts / conversion of below-target performance awards","excerpt":"As disclosed in our 2025 Proxy Statement, in the first quarter of 2025, the Compensation Committee, with input from the Company's independent compensation consultant, determined to convert the portion of our 2023-2025 PSU awards attributable to key Human Capital Management goals (representing 17% of the original award) into time-based RSUs based on performance results for those goals through the end of 2024, which were below target."},{"id":"e25","sourceId":"filing-3","location":"2023–2025 PSU Performance and Payouts / disclosed effect of conversion","excerpt":"This conversion of the PSUs, which was generally supported by the stockholders we engaged with through our outreach program, resulted in no incremental expense recognized by the Company and no incremental value delivered to the Named Executive Officers."},{"id":"e26","sourceId":"filing-3","location":"2023–2025 PSU Performance and Payouts / January 2026 vesting","excerpt":"The resulting RSUs vested on January 2, 2026, which was the first business day following the end of the original three-year performance period."},{"id":"e27","sourceId":"filing-3","location":"CEO employment agreement / termination-related maximum vesting","excerpt":"•full vesting of all outstanding restricted stock, stock options and other performance-related compensation, including any cash-based performance share units, assuming maximum payout for any open performance cycles;"},{"id":"e28","sourceId":"filing-3","location":"Corporate Governance / independent director appointments","excerpt":"We have appointed four new independent directors to the Board of Directors within the past five years."},{"id":"e29","sourceId":"filing-3","location":"Audit Matters / auditor independence procedures","excerpt":"Our Audit and Compliance Committee observes and implements certain procedures relating to the pre-approval of all audit and permissible non-audit services performed by KPMG to ensure that the provision of such services and related fees does not impair the firm’s independence."},{"id":"e30","sourceId":"filing-3","location":"Board succession planning / adopted emergency plan","excerpt":"Our Board has adopted an emergency succession plan to facilitate the transition to both interim and long-term leadership in the event of an unexpected vacancy in the position of CEO."},{"id":"e31","sourceId":"filing-2","location":"2026 Highlights / completed senior housing acquisitions","excerpt":"2026 Highlights Investments and Dispositions •In our SHOP segment, during the six months ended June 30, 2026, we acquired 61 senior housing communities for an aggregate purchase price of $2.8 billion."}],"changes":["Changed the verdict from uncertain to none because the supplied explicit disclosure of limited development barriers, combined with senior housing's majority NOI contribution, supports a structural no-moat judgment. This is not a finding of weak current execution.","Recognized 2025 RevPOR growth of 4.7% as evidence of realized pricing strength, qualified because revenue per occupied room can also reflect service and resident mix.","Added numerical management assessments using actual financing, operating results, compensation arrangements and governance disclosures; identified award conversion and termination benefits as alignment concerns."],"limitations":["All supplied sources are issuer filings. Reported operating results and contractual terms support assessments, while descriptions of an advantaged platform and proprietary analytics remain management assertions.","No named company is established as a direct competitor in the supplied competitive evidence. Named tenants, operators, index constituents and executives' former employers are not treated as competitors; competitor arrays are therefore empty.","The passages lack comparative property costs, rent premiums, exclusive hospital relationships and demonstrated tenant switching costs. Local advantages may exist without establishing a portfolio-wide moat.","RevPOR and occupancy evidence concerns 2025. No resident retention rate, renewal spread series or complete current-period property revenue and expense comparison is supplied.","The proxy is supplied, but detailed executive ownership holdings are absent. Incentive design and actual award treatment support alignment assessment without assuming ownership.","Generic supply, funding and renewal risks are possible erosion channels, not evidence that those adverse outcomes have occurred. The 2026 impairment charges are realized accounting outcomes.","All source dates retain dateKind filed. Later publication of the April 2026 proxy does not turn its 2025 operating results into 2026 operating performance."],"qualityAssessments":[{"category":"moat","checks":[{"criterion":"structural_advantage","grade":1,"rationale":"Scale and hospital affiliations are established, but comparative cost savings, exclusivity and customer lock-in are not. Explicitly limited development barriers weaken structural protection in the majority-NOI senior housing business.","evidenceIds":["e1","e5","e9","e12"]},{"criterion":"durability","grade":1,"rationale":"Locations and the operating platform persist, but the evidence does not demonstrate durable competitive rents through a supply cycle. Limited entry barriers and uncertain renewal economics make protection fragile.","evidenceIds":["e2","e4","e9"]},{"criterion":"customer_dependency","grade":1,"rationale":"Hospital-campus positioning provides a plausible reason for tenant demand, but no exclusive access, switching expense or demonstrated renewal dependence is disclosed. Occupancy growth establishes demand rather than dependency.","evidenceIds":["e2","e14","e4"]},{"criterion":"erosion_resilience","grade":2,"rationale":"Strong same-store growth provides evidence of current operating resilience. Low development barriers, third-party operating dependence and actual impairments limit conclusions about resilience to competitive erosion.","evidenceIds":["e8","e9","e10","e21"]}]},{"category":"pricing_power","checks":[{"criterion":"realized_pricing","grade":2,"rationale":"2025 RevPOR increased 4.7%, accompanied by an issuer description of broad pricing strength. This is a positive observed revenue-per-room outcome, but it does not isolate pure price changes from mix or establish multiyear pricing durability.","evidenceIds":["e13"]},{"criterion":"retention","grade":2,"rationale":"Same-store average occupancy increased 300 basis points alongside RevPOR growth, supporting demand at higher revenue per occupied room. This is indirect demand evidence; it does not establish resident retention or tenant renewal rates.","evidenceIds":["e14","e13"]},{"criterion":"margin_resilience","grade":2,"rationale":"SHOP same-store cash NOI growth above 15% and company same-store cash NOI growth of 8% demonstrate improved property cash earnings. Occupancy recovery contributes, and supplied expense detail cannot isolate pricing-led margin protection; same-store exclusions also narrow coverage.","evidenceIds":["e15","e8","e14","e16"]},{"criterion":"contractual_freedom","grade":2,"rationale":"Fixed lease payments constrain repricing during contractual terms, while percentage rent, expense reimbursements and tenant capital obligations provide contractual protection. No broad unilateral repricing right is demonstrated.","evidenceIds":["e17","e18","e19"]}]},{"category":"strong_management","checks":[{"criterion":"capital_discipline","grade":2,"rationale":"2025 per-share FFO growth and leverage reduction support productive capital deployment. First-half 2026 operating cash flow rose to $951.2 million, but expansion relied heavily on equity issuance, outstanding shares increased and $60.3 million of impairments were recognized. Acquisition return expectations remain unproven outcomes.","evidenceIds":["e8","e22","e20","e11","e21","e31"]},{"criterion":"incentive_alignment","grade":2,"rationale":"The 2025 CEO long-term incentive mix was 70% PSUs and 30% RSUs. However, a below-target portion of earlier performance awards was converted into time-based awards that vested in January 2026, and specified CEO termination terms allow maximum performance vesting. The issuer reports no incremental value from the conversion. Actual ownership levels are missing.","evidenceIds":["e23","e24","e25","e26","e27"]},{"criterion":"execution","grade":3,"rationale":"Demonstrated 2025 per-share FFO growth, same-store growth, occupancy improvement and RevPOR growth support strong execution, reinforced by higher first-half 2026 operating cash generation. This assessment uses operating outcomes rather than proving that analytics or management alone caused them; acquisition integration returns remain incomplete.","evidenceIds":["e8","e13","e14","e15","e20"]},{"criterion":"governance","grade":2,"rationale":"Actual independent director appointments, auditor pre-approval procedures and an adopted emergency succession plan provide meaningful governance infrastructure. Performance-award conversion and generous CEO termination vesting temper the assessment; the supplied coverage does not establish exceptional board effectiveness.","evidenceIds":["e28","e29","e30","e24","e27"]}]}],"financialAssessments":[],"qualityPolicy":"quality-scores-2","sourcePolicy":"issuer-evidence-4","basisHash":"8779700e2b8d9bb9d5b38af0d6400805d8868f96ba2e3112364435bbfd8d761e","updatedAt":"2026-10-18T13:34:28.034Z","sources":[{"id":"filing-1","url":"https://www.sec.gov/Archives/edgar/data/740260/000074026026000006/vtr-20251231.htm","publishedAt":"2026-02-06","sha256":"cc2a9cdf5c1eaa5ac92ad0654411cd211c1011d535a7e67f5ea5c27b65482cd3","dateKind":"filed"},{"id":"filing-2","url":"https://www.sec.gov/Archives/edgar/data/740260/000074026026000024/vtr-20260630.htm","publishedAt":"2026-07-30","sha256":"a2079c5a4009f3ddf296399eabb8dbf2a929ee7265385c2910872c442ff764e1","dateKind":"filed"},{"id":"filing-3","url":"https://www.sec.gov/Archives/edgar/data/740260/000074026026000010/vtr-20260401.htm","publishedAt":"2026-04-01","sha256":"36015568538729f10e39ea6eab500f3520e45cb2b57c2a90576c2b066671bf33","dateKind":"filed"},{"id":"filing-4","url":"https://www.sec.gov/Archives/edgar/data/740260/000074026025000052/vtr-20241231.htm","publishedAt":"2025-02-13","sha256":"5b8e7bc69fb2faed0a0dac4695088123862aff10695da381de9a74eaea25148a","dateKind":"filed"},{"id":"filing-5","url":"https://www.sec.gov/Archives/edgar/data/740260/000074026024000067/vtr-20231231.htm","publishedAt":"2024-02-15","sha256":"52715eb5e25ba4467fe4cb1287caeea5d209b605cdc6d198d8ec4af69a482125","dateKind":"filed"},{"id":"filing-6","url":"https://www.sec.gov/Archives/edgar/data/740260/000074026026000018/vtr-20260331.htm","publishedAt":"2026-04-28","sha256":"7569efde7befc975a32d58239a5bad518ed41d4d2f1a52325d275feaceb88c7b","dateKind":"filed"}],"model":"gpt-6.1-sol","providerId":"codex:1985a528b10e355e51c3a980a077a6317a434506e7f702275c49bff81a2d99db","usage":{"input_tokens":86152,"cached_input_tokens":21120,"cache_write_input_tokens":0,"output_tokens":3575,"reasoning_output_tokens":223},"basisSupplement":{"previousHash":"531d9108f7be6c92e4b081955d32e64169a69b04f432b9a00cab0ce0852282ec","checkedAt":"2026-10-18T16:49:32.080Z","rule":"dated historical and missing inputs only; accepted observations and research date retained"}},"signals":[{"period":"2021","end":"2021-12-31","values":{"gross_margin":null,"operating_margin":null,"roic":null,"fcf_margin":-20.269163562135596,"sbc_revenue":0.8350559442550655},"issues":{"peg":"TTM earnings per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","pfcf":"Trailing free cash flow is zero or negative, so this ratio is undefined.","pfcf_growth":"TTM FCF per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","ev_ebitda":"Operating income is unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","sbc_fcf":"Free cash flow before SBC deduction is zero or negative, so this ratio is undefined.","gross_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Operating income is unavailable in the extracted statements for this period.","roic":"NOPAT is undefined under this method: pretax profit must be positive and the effective tax rate must be between 0 and 100%.","roce":"Operating income is unavailable in the extracted statements for this period.","roiic":"NOPAT is undefined under this method: pretax profit must be positive and the effective tax rate must be between 0 and 100%.","roic_wacc":"Enter a WACC assumption from 0 to 100%.","net_debt_ebitda":"Operating income is unavailable in the extracted statements for this period.","debt_fcf":"Trailing free cash flow is zero or negative, so this ratio is undefined.","interest_coverage":"Operating income is unavailable in the extracted statements for this period.","current_ratio":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","buybacks":"The reported inputs required for this metric are unavailable in the extracted statements for this period."}},{"period":"2022","end":"2022-12-31","values":{"gross_margin":null,"operating_margin":null,"roic":null,"fcf_margin":5.315009494591315,"sbc_revenue":0.7438499484039617},"issues":{"pe":"Trailing earnings is zero or negative, so this ratio is undefined.","peg":"TTM earnings per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","pfcf_growth":"Prior-year TTM FCF per diluted share is zero or negative; a growth-adjusted multiple is undefined.","ev_ebitda":"Operating income is unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","gross_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Operating income is unavailable in the extracted statements for this period.","roic":"NOPAT is undefined under this method: pretax profit must be positive and the effective tax rate must be between 0 and 100%.","roce":"Operating income is unavailable in the extracted statements for this period.","roiic":"Invested capital did not increase versus the prior year. ROIIC requires a positive increase.","roic_wacc":"Enter a WACC assumption from 0 to 100%.","net_debt_ebitda":"Operating income is unavailable in the extracted statements for this period.","interest_coverage":"Operating income is unavailable in the extracted statements for this period.","current_ratio":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","buybacks":"The reported inputs required for this metric are unavailable in the extracted statements for this period."}},{"period":"2023","end":"2023-12-31","values":{"gross_margin":null,"operating_margin":null,"roic":null,"fcf_margin":10.458428036471833,"sbc_revenue":0.6889326779353674},"issues":{"pe":"Trailing earnings is zero or negative, so this ratio is undefined.","peg":"Prior-year TTM earnings per diluted share is zero or negative; a growth-adjusted multiple is undefined.","ev_ebitda":"Operating income is unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","gross_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Operating income is unavailable in the extracted statements for this period.","roic":"NOPAT is undefined under this method: pretax profit must be positive and the effective tax rate must be between 0 and 100%.","roce":"Operating income is unavailable in the extracted statements for this period.","roiic":"Invested capital did not increase versus the prior year. ROIIC requires a positive increase.","roic_wacc":"Enter a WACC assumption from 0 to 100%.","net_debt_ebitda":"Operating income is unavailable in the extracted statements for this period.","interest_coverage":"Operating income is unavailable in the extracted statements for this period.","current_ratio":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","buybacks":"The reported inputs required for this metric are unavailable in the extracted statements for this period."}},{"period":"2024","end":"2024-12-31","values":{"gross_margin":null,"operating_margin":null,"roic":null,"fcf_margin":-24.37272884933511,"sbc_revenue":0.6293526791607115},"issues":{"peg":"Prior-year TTM earnings per diluted share is zero or negative; a growth-adjusted multiple is undefined.","pfcf":"Trailing free cash flow is zero or negative, so this ratio is undefined.","pfcf_growth":"TTM FCF per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","ev_ebitda":"Operating income is unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","sbc_fcf":"Free cash flow before SBC deduction is zero or negative, so this ratio is undefined.","gross_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Operating income is unavailable in the extracted statements for this period.","roic":"NOPAT is undefined under this method: pretax profit must be positive and the effective tax rate must be between 0 and 100%.","roce":"Operating income is unavailable in the extracted statements for this period.","roiic":"NOPAT is undefined under this method: pretax profit must be positive and the effective tax rate must be between 0 and 100%.","roic_wacc":"Enter a WACC assumption from 0 to 100%.","net_debt_ebitda":"Operating income is unavailable in the extracted statements for this period.","debt_fcf":"Trailing free cash flow is zero or negative, so this ratio is undefined.","interest_coverage":"Operating income is unavailable in the extracted statements for this period.","current_ratio":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","buybacks":"The reported inputs required for this metric are unavailable in the extracted statements for this period."}},{"period":"2025","end":"2025-12-31","values":{"gross_margin":null,"operating_margin":null,"roic":null,"fcf_margin":-21.96344519521836,"sbc_revenue":0.6639206853640225},"issues":{"pfcf":"Trailing free cash flow is zero or negative, so this ratio is undefined.","pfcf_growth":"Prior-year TTM FCF per diluted share is zero or negative; a growth-adjusted multiple is undefined.","ev_ebitda":"Operating income is unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","sbc_fcf":"Free cash flow before SBC deduction is zero or negative, so this ratio is undefined.","gross_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Operating income is unavailable in the extracted statements for this period.","roic":"NOPAT is undefined under this method: pretax profit must be positive and the effective tax rate must be between 0 and 100%.","roce":"Operating income is unavailable in the extracted statements for this period.","roiic":"NOPAT is undefined under this method: pretax profit must be positive and the effective tax rate must be between 0 and 100%.","roic_wacc":"Enter a WACC assumption from 0 to 100%.","net_debt_ebitda":"Operating income is unavailable in the extracted statements for this period.","debt_fcf":"Trailing free cash flow is zero or negative, so this ratio is undefined.","interest_coverage":"Operating income is unavailable in the extracted statements for this period.","current_ratio":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","buybacks":"The reported inputs required for this metric are unavailable in the extracted statements for this period."}}],"sources":[{"id":"filing-1","url":"https://www.sec.gov/Archives/edgar/data/740260/000074026026000006/vtr-20251231.htm","publishedAt":"2026-02-06","sha256":"cc2a9cdf5c1eaa5ac92ad0654411cd211c1011d535a7e67f5ea5c27b65482cd3","dateKind":"filed"},{"id":"filing-2","url":"https://www.sec.gov/Archives/edgar/data/740260/000074026026000024/vtr-20260630.htm","publishedAt":"2026-07-30","sha256":"a2079c5a4009f3ddf296399eabb8dbf2a929ee7265385c2910872c442ff764e1","dateKind":"filed"},{"id":"filing-3","url":"https://www.sec.gov/Archives/edgar/data/740260/000074026026000010/vtr-20260401.htm","publishedAt":"2026-04-01","sha256":"36015568538729f10e39ea6eab500f3520e45cb2b57c2a90576c2b066671bf33","dateKind":"filed"},{"id":"filing-4","url":"https://www.sec.gov/Archives/edgar/data/740260/000074026025000052/vtr-20241231.htm","publishedAt":"2025-02-13","sha256":"5b8e7bc69fb2faed0a0dac4695088123862aff10695da381de9a74eaea25148a","dateKind":"filed"},{"id":"filing-5","url":"https://www.sec.gov/Archives/edgar/data/740260/000074026024000067/vtr-20231231.htm","publishedAt":"2024-02-15","sha256":"52715eb5e25ba4467fe4cb1287caeea5d209b605cdc6d198d8ec4af69a482125","dateKind":"filed"},{"id":"filing-6","url":"https://www.sec.gov/Archives/edgar/data/740260/000074026026000018/vtr-20260331.htm","publishedAt":"2026-04-28","sha256":"7569efde7befc975a32d58239a5bad518ed41d4d2f1a52325d275feaceb88c7b","dateKind":"filed"}],"history":[{"version":4,"updatedAt":"2026-10-18T16:49:32.080Z","verdict":"none","value":null},{"version":3,"updatedAt":"2026-10-18T16:35:43.872Z","verdict":"none","value":null},{"version":2,"updatedAt":"2026-10-18T02:27:49.793Z","verdict":"uncertain","value":null},{"version":1,"updatedAt":"2026-10-18T02:18:02.026Z","verdict":null,"value":null}],"hasRequested":false,"requestStatus":"completed","researchIssue":null,"archivedMoat":null,"scope":"supported_catalog"}